Utilizing our advanced in vitro RCC model, we demonstrated that the immunogenic effects of the SARS-CoV-2 S protein on renal epithelial cells are amplified in the presence of RCC, highlighting the synergistic impact of cancer and viral factors on renal cell behavior. This evidence concerns the gene PROS1 and renal cell carcinoma.